Related Experiment Video
Updated: Aug 23, 2025
12:25
Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
Published on: January 7, 2014
15.4K
Glioblastoma stem cell HISTArionics.
Siva Kumar Natarajan1, Sriram Venneti2
1Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
Cell Stem Cell
|November 4, 2022
Summary
Glioblastoma stem cells (GSCs) drive tumor growth and resistance by controlling blood vessel formation through histamine. Antihistamines may offer a new therapeutic strategy against these aggressive brain cancers.
Area of Science:
- Neuro-oncology
- Cancer biology
- Epigenetics and metabolism
Background:
- Glioblastomas are aggressive brain tumors with a complex microenvironment.
- Glioblastoma stem cells (GSCs) are critical drivers of tumor progression, recurrence, and resistance to therapy.
- The tumor microenvironment features necrotic/hypoxic regions and aberrant vasculature, contributing to malignancy.
Purpose of the Study:
- To investigate the role of glioblastoma stem cells (GSCs) in regulating the tumor microenvironment.
- To elucidate the mechanisms by which GSCs control angiogenesis.
- To explore the potential of targeting GSC-driven pathways with existing drugs.
Main Methods:
- Analysis of GSC-mediated epigenetic and metabolic regulation.
- Investigation of histamine signaling in tumor angiogenesis.
- Preclinical evaluation of antihistamines as a therapeutic approach.
Main Results:
- GSCs were found to orchestrate an integrated epigenetic and metabolic program.
- Histamine was identified as a key mediator of GSC-driven angiogenesis.
- Targeting histamine signaling showed promise in preclinical models.
Conclusions:
- Glioblastoma stem cells (GSCs) play a crucial role in tumor angiogenesis through integrated epigenetic and metabolic control mediated by histamine.
- Antihistamines represent a potential therapeutic avenue for glioblastoma by disrupting GSC-driven angiogenesis and improving treatment outcomes.
